Charitable organizations are seeing more and more patients who need financial assistance, said Dan Klein, President and CEO, Patient Access Network (PAN) Foundation.
Charitable organizations are seeing more and more patients who need financial assistance, said Dan Klein, President and CEO, Patient Access Network (PAN) Foundation.
Transcript
More people are getting insurance, but plans are also shifting more financial burden to patients. Have changes like these resulted in any changes that you’ve seen from your end of providing financial assistance to patients?
We’re seeing more and more patients with high-deductible plans and more patients in Medicare who are reaching the catastrophic threshold. And, as a result, we’re seeing more demand for the types of grants and assistance that we provide. The numbers just seem to grow every year, and it’s a challenge to keep up.
We mainly serve Medicare patients—so about 85% to 90% of the patients we serve are on Medicare. As a result of the Affordable Care Act rolling out, obviously more people did get coverage, but those aren’t really the people who generally come to us for grants. Now, what’s potentially change is, one, people are coming off the Affordable Care Act coverage because of the changes that the new administration has put in place and, also, there’s this new emerging trend of something called accumulator adjusters that may make manufacturer coupons less useful for patients with commercial coverage. So those patients might start to look to charitable foundations like PAN for assistance. So, we could see an increase as a result of that.
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Prostate Cancer Studies Show Why Personalized Treatment, Trial Diversity Matter, Dorff Says
February 21st 2025Tanya B. Dorff, MD, medical oncologist and professor in City of Hope’s Department of Medical Oncology & Therapeutics Research, was a discussant for the TALAPRO-2 and STOPCAP trials at the opening session of ASCO GU.
Read More
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More